Scinovex
article Open AccessTop 1% cited

COVID-19 pandemic, coronaviruses, and diabetes mellitus

American Journal of Physiology-Endocrinology and Metabolism · 2020 · Vol. 318(5) · pp. E736–E741
Ranganath MuniyappaSriram Gubbi

Abstract

The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing substantial morbidity and mortality. Older age and presence of diabetes mellitus, hypertension, and obesity significantly increases the risk for hospitalization and death in COVID-19 patients. In this Perspective, informed by the studies on SARS-CoV-2, Middle East respiratory syndrome (MERS-CoV), and the current literature on SARS-CoV-2, we discuss potential mechanisms by which diabetes modulates the host-viral interactions and host-immune responses. We hope to highlight gaps in knowledge that require further studies pertinent to COVID-19 in patients with diabetes.

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19PandemicDiabetes mellitusCoronavirus disease 2019 (COVID-19)MedicineCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Middle East respiratory syndrome coronavirusDiseaseMiddle East respiratory syndromeIntensive care medicine

MeSH terms

UncertaintyPandemicsBetacoronavirusHost Microbial InteractionsCOVID-19SARS-CoV-2AnimalsDiabetes MellitusHumansPneumonia, ViralUnited StatesCoronavirus InfectionsRisk Assessment

Funding

  • National Institute of Diabetes and Digestive and Kidney Diseases
Citations
890
FWCI
20.55
field-weighted impact
References
53
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.